Logo: Four dots and StockDot set in typeface Coolvetica
An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for NEUROCRINE BIOSCIENCES Inc
Ticker NBIX
FIGI BBG000GJS7C1
CUSIP 64125C109
Sector Healthcare
Equity Type Common Stock
No. Companies Holding this Equity 556 / 8.1%
Percentage held by institutional investors 91.9%

About

Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. Wikipedia